Skip to main content
. 2013 Jul 5;8(7):e68328. doi: 10.1371/journal.pone.0068328

Figure 3. Effects of SPHK inhibition on cell viability.

Figure 3

The human melanoma cell line WM266.4 (panel A) and the human glioblastoma cell line LN229 (panel B) were treated for 72 h with the indicated concentrations of compound A (left panel) and compound B (right panel). Viability was assessed after 72 h.